New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases

Neurol Sci. 2020 Jul;41(7):1657-1658. doi: 10.1007/s10072-020-04484-5. Epub 2020 May 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Betacoronavirus / drug effects*
  • COVID-19
  • COVID-19 Serotherapy
  • Coronavirus Infections / complications
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / therapy
  • Guillain-Barre Syndrome / complications
  • Guillain-Barre Syndrome / drug therapy*
  • Guillain-Barre Syndrome / virology
  • Humans
  • Immunization, Passive
  • Immunoglobulins, Intravenous / therapeutic use*
  • Italy
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • Immunoglobulins, Intravenous